DNAM-1 role in tumor clearance appears to be particularly important for tumors that do not express other ligands for activating NK cell receptors (for example NKG2D), suggesting that the DNAM-1/DNAM-1 ligand axis extends NK cells capability to eliminate tumor cells [76]. Here, CD226 is linked to neoplasm.